Expression of X‐linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: X‐linked inhibitor of apoptosis protein (XIAP) is a member of the inhibitor of apoptosis family of proteins and deregulation of XIAP can result in tumorigenicity. The objective of this study was to evaluate the prognostic significance of XIAP expression in colorectal cancer (CRC). Methods: RT‐PCR was performed to detect the expression of XIAP mRNA in CRC cells and tissues. The expression of XIAP protein in tissues was measured by immunohistochemistry. The correlation of XIAP expression with clinicopathologic factors and prognosis of CRC patients was evaluated. Results: CRC cells showed significantly higher levels of XIAP mRNA expression than normal human intestinal epithelial cell. The expression level of XIAP mRNA in CRC samples was significantly higher than that in corresponding non‐tumor samples. XIAP staining was positive in the cytoplasm of CRC cells. Higher XIAP protein expression was significantly correlated with tumor differentiation (P = 0.016), venous invasion (P = 0.039), and Duke's staging (P = 0.002). Moreover, XIAP‐high group showed lower disease‐free (P = 0.0136) and overall survival (P = 0.0084) rates than XIAP‐low group. Multivariate analysis indicated that the status of XIAP expression was an independent prognostic factor for CRC (P = 0.0206; HR: 2.730; 95% CI: 1.226–5.445). Conclusion: The status of XIAP expression might become an independent prognostic marker for CRC. J. Surg. Oncol. 2009;100:708–712. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Connolly, K., Mitter, R., Muir, M., Jodrell, D., & Guichard, S. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0872-x · Cited by 34 · cited 1×
“Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro [22].”
Background
Cited by
Targeting IAP proteins for therapeutic intervention in cancer
Fulda, S., & Vucic, D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3627 · Cited by 837
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review
Rascio, F., Spadaccino, F., Rocchetti, M. T., Castellano, G., Stallone, G., Netti, G. S., & Ranieri, E. (2021) · Cancers · doi:10.3390/cancers13163949 · Cited by 497
Apoptotic cell signaling in cancer progression and therapy
Plati, J., Bucur, O., & Khosravi-Far, R. (2011) · Integrative Biology · doi:10.1039/c0ib00144a · Cited by 319
Small-molecule SMAC mimetics as new cancer therapeutics
Bai, L., Smith, D. C., & Wang, S. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.05.007 · Cited by 210
“Similarly, elevated levels of XIAP are correlated with poor prognosis in colorectal cancer [61, 62], prostate cancer [63, 64], chronic lymphocytic leukemia [65] and many other types of human cancer.”
BackgroundMolecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant
Fichtner, M., Bozkurt, E., Salvucci, M., McCann, C., McAllister, K. A., Halang, L., Düssmann, H., Kinsella, S., Crawford, N., Sessler, T., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03232-z · Cited by 28
Metadata
- Authors
- Guoan, X., Xiaomin, W., Hanning, W., Kaiyun, C., & Hao, L.
- Venue
- Journal of Surgical Oncology
- Publisher
- Wiley
- Published
- 2009-09-23
- Volume
- 100
- Issue
- 8
- Pages
- 708-712
- ISSN
- 0022-4790 (ISSN-L)
- 1096-9098
- OpenAlex
- W2139641636
- Cited by
- 69
- References
- 1
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of X‐linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis. https://app.cochat.ai/papers/10.1002/jso.21408
- The paper
- Guoan, X., Xiaomin, W., Hanning, W., Kaiyun, C., & Hao, L. (2009). Expression of X‐linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis. Journal of Surgical Oncology. https://doi.org/10.1002/jso.21408
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.